National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 3) (PB 40 of 2020) (Cth)

PB 40 of 2020

National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 3)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 29 April 2020

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2020 (No. 3).

(2)This Instrument may also be cited as PB 40 of 2020.

1. Commencement

This Instrument commences on 1 May 2020.

1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

1. Schedule 1, omit entry for Montelukast

1. Schedule 1, entry for Simvastatin

Omit:

Simvastatin	Tablet 10 mg	Oral	Lipex 10	30	1.04	6.00
Zocor	30	1.04	6.00
Tablet 20 mg	Oral	Lipex 20	30	1.51	8.48
Zocor	30	1.51	8.48
Tablet 40 mg	Oral	Lipex 40	30	2.17	9.14
Zocor	30	2.17	9.14
Tablet 80 mg	Oral	Lipex 80	30	3.10	10.97
Zocor	30	3.10	10.97

Substitute:

Simvastatin	Tablet 10 mg	Oral	Lipex 10	30	1.04	6.00
Zocor	30	1.04	6.00
Tablet 20 mg	Oral	Lipex 20	30	1.51	8.48
Zocor	30	1.51	8.48
Tablet 40 mg	Oral	Lipex 40	30	2.17	9.14
Zocor	30	2.17	9.14